{
  "docId": "019de073-ed1e-723c-a28e-3c378280574e",
  "docSlug": "3439c61eec2c1805f58a361a1d0fbc84",
  "documentTitle": "ATAI | Investor Presentation Deck | 36 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 29,
  "pageCount": 36,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a checkmark matrix to highlight the competitive advantage of the company's drug candidate.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-ed1e-723c-a28e-3c378280574e/29",
  "deckHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e",
  "deckJsonHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e.json",
  "deckAnchorHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e#slide-29",
  "components": [
    {
      "bbox": {
        "h": 0.72,
        "w": 0.21,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "There is an unmet need in GAD for therapies with rapid onset, high efficacy, and minimal side effects. SSRI's are current standard of care for GAD but require 4-6 weeks for onset of effect and have several disadvantages. Benzodiazepines are second-line treatment, offering fast and effective relief, but carrying significant risk of sedation, impaired cognition, and dependence/addiction.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad0a4496-80cb-4e1f-ab74-4297b6b1e1c8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.71,
        "x": 0.27,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Note: GABA = Gamma aminobutyric acid, SERT = serotonin transporter, NET = serotonin transporter, MoA = Mechanism of Action; 5HT1a = serotonin 1A receptor; VDCC = voltage dependent calcium channel; TSPO = mitochondrial translocator protein. Source: GlobalData, Evaluate Pharma (both as of 19.03.2021) (1) DeMartini et al., “Generalized Anxiety Disorder” (2019)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62a543ad-6214-48ec-b5f6-110efec2cee7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.71,
        "x": 0.27,
        "y": 0.18
      },
      "kind": "table",
      "text": "Overview of Current Therapeutic Options for Generalized Anxiety Disorder",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7458816f-f1a4-4a42-9708-5585649b14ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.68,
        "x": 0.27,
        "y": 0.06
      },
      "kind": "title",
      "text": "GRX-917 can fill unmet need in Generalized Anxiety Disorder (GAD) with rapid onset and favorable safety profile",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6e0ee27-f5d0-4607-b5a4-f02159257ab9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_table",
      "slug": null,
      "matchId": "799ab1be-7394-403c-b004-4a8a90547d53",
      "evidence": "The slide uses a matrix to compare the company's product against competitors across multiple attributes.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}